Lyell Immunopharma (LYEL)
Develops CAR T-cell candidates for lymphoma and metastatic colorectal cancer.
$15.10
Pre-market+0.14 (+0.94%)
At close$14.96(+2.96%)
Something off on this page? Send us feedback.
Next report
Nov 10, 2026
estimated · in 68 days
EPS estimate
−$2.06
Revenue estimate
$3.8K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.72−$3.60−$2.89−$2.13−$7.68−$1.10−$1.92Pending
Estimate−$0.18−$3.80−$3.80−$2.81−$2.15−$2.78−$1.90−$2.06
Surprise−300.0%+5.3%+23.9%+24.2%−257.2%+60.4%−1.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$11.0K$7.0K$8.0K$15.0K$6.0K$2.0K$4.0KPending
Estimate——$4.0K—$15.3K$3.0K$3.6K$3.8K
Surprise——+100.0%—−60.7%−33.3%+10.3%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.06 | — | — |
| Aug 2026 | −$1.90 | −$1.92 | −1.1% |
| May 2026 | −$2.78 | −$1.10 | +60.4% |
| Mar 2026 | −$2.15 | −$7.68 | −257.2% |
| Nov 2025 | −$2.81 | −$2.13 | +24.2% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | −$2.06 | — | — | $3.8K | — | — | — |
| Aug 6, 2026 | −$1.90 | −$1.92 | −1.1% | $3.6K | $4.0K | +10.3% | +3.5% |
| May 6, 2026 | −$2.78 | −$1.10 | +60.4% | $3.0K | $2.0K | −33.3% | −3.8% |
| Mar 12, 2026 | −$2.15 | −$7.68 | −257.2% | $15.3K | $6.0K | −60.7% | −14.3% |
| Nov 12, 2025 | −$2.81 | −$2.13 | +24.2% | — | $15.0K | — | −1.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 6, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| Jun 18, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
